Literature DB >> 17119048

Risk of squamous cell carcinoma of the upper aerodigestive tract in cancer-free alcoholic Japanese men: an endoscopic follow-up study.

Akira Yokoyama1, Tai Omori, Tetsuji Yokoyama, Yasuo Sato, Takeshi Mizukami, Sachio Matsushita, Susumu Higuchi, Katsuya Maruyama, Hiromasa Ishii, Toshifumi Hibi.   

Abstract

Asian case-control studies have shown a strong relationship between the development of squamous cell carcinoma (SCC) of the esophagus and alcohol consumption combined with inactive aldehyde dehydrogenase-2 (ALDH2*1/*2), less-active alcohol dehydrogenase-1B (ADH1B*1/*1), high mean corpuscular volume (MCV), and self-reported facial flushing in response to alcohol. However, little is known about whether these risk factors prospectively influence cancer development in cancer-free alcoholics. Between 1993 and 2005, 808 Japanese alcoholic men diagnosed as cancer-free by an initial endoscopic screening examination received follow-up examinations ranging from 1 to 148 months (median, 31 months) later, and SCC of the upper aerodigestive tract was diagnosed in 53 of them (esophagus in 33 and oropharyngolarynx in 30). Cox proportional hazards analysis showed that the age-adjusted relative hazard for SCC was 11.55 [95% confidence interval (95% CI), 5.73-23.3] in ALDH2*1/*2 heterozygotes compared with ALDH2*1/*1 homozygotes, 2.02 (95% CI, 1.02-4.02) in ADH1B*1/*1 homozygotes compared with ADH1B*1/*2 heterozygotes or *2/*2 homozygotes, 2.64 (95% CI, 1.49-4.67) in patients with flushing compared with those who had never experienced flushing, 2.91 (95% CI, 1.63-5.20) in those with an MCV >or= 106 compared with those with an MCV < 106, 2.52 (95% CI, 1.22-5.22) in those who smoked >or=30 cigarettes per day compared with those who smoked 0 to 19 cigarettes per day, 7.26 (95% CI, 3.99-13.23) in those with esophageal dysplasia compared with those without distinct iodine-unstained lesions >or=5 mm, and 0.28 (95% CI, 0.09-0.85) in those with body mass index >or= 23.2 (highest quartile) compared with those with body mass index < 19.0 (lowest quartile). These predictors are useful for selecting appropriately patients for careful follow-up examinations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17119048     DOI: 10.1158/1055-9965.EPI-06-0435

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  19 in total

1.  The association between change in body mass index and upper aerodigestive tract cancers in the ARCAGE project: multicenter case-control study.

Authors:  Sungshim Lani Park; Yuan-Chin Amy Lee; Manuela Marron; Antonio Agudo; Wolfgang Ahrens; Luigi Barzan; Vladimir Bencko; Simone Benhamou; Christine Bouchardy; Cristina Canova; Xavier Castellsague; David I Conway; Claire M Healy; Ivana Holcátová; Kristina Kjaerheim; Pagona Lagiou; Raymond J Lowry; Tatiana V Macfarlane; Gary J Macfarlane; Bernard E McCartan; Patricia A McKinney; Franco Merletti; Hermann Pohlabeln; Lorenzo Richiardi; Lorenzo Simonato; Linda Sneddon; Renato Talamini; Dimitrios Trichopoulos; Ariana Znaor; Paul Brennan; Mia Hashibe
Journal:  Int J Cancer       Date:  2011-03-15       Impact factor: 7.396

2.  p53 immunohistochemical expression and patient prognosis in esophageal squamous cell carcinoma.

Authors:  Asuka Murata; Yoshifumi Baba; Masayuki Watanabe; Hironobu Shigaki; Keisuke Miyake; Ryuichi Karashima; Yu Imamura; Satoshi Ida; Takatsugu Ishimoto; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Hideo Baba
Journal:  Med Oncol       Date:  2013-09-13       Impact factor: 3.064

3.  Genetic polymorphisms in cytochrome P4502E1, alcohol and aldehyde dehydrogenases and the risk of esophageal squamous cell carcinoma in Gansu Chinese males.

Authors:  Yan-Mei Guo; Qin Wang; Yan-Zhen Liu; Huei-Min Chen; Zhi Qi; Qing-Hong Guo
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

Review 4.  Genetic approaches to addiction: genes and alcohol.

Authors:  Francesca Ducci; David Goldman
Journal:  Addiction       Date:  2008-04-16       Impact factor: 6.526

5.  Association between macrocytosis and metachronous squamous cell carcinoma of the esophagus after endoscopic resection in men with early esophageal squamous cell carcinoma.

Authors:  Chikatoshi Katada; Tetsuji Yokoyama; Tomonori Yano; Ichiro Oda; Yuichi Shimizu; Hisashi Doyama; Tomoyuki Koike; Kohei Takizawa; Motohiro Hirao; Hiroyuki Okada; Takako Yoshii; Yutaro Kubota; Takenori Yamanouchi; Takashi Tsuda; Tai Omori; Nozomu Kobayashi; Haruhisa Suzuki; Satoshi Tanabe; Keisuke Hori; Norisuke Nakayama; Hirofumi Kawakubo; Naomi Kakushima; Yasumasa Matsuo; Hideki Ishikawa; Akira Yokoyama; Manabu Muto
Journal:  Esophagus       Date:  2019-07-08       Impact factor: 4.230

6.  Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.

Authors:  Yuki Matsumura; Na Li; Hanan Alwaseem; Odelya E Pagovich; Ronald G Crystal; Matthew B Greenblatt; Katie M Stiles
Journal:  Hum Gene Ther       Date:  2020-01-28       Impact factor: 5.695

Review 7.  Molecular mechanisms of ethanol-associated oro-esophageal squamous cell carcinoma.

Authors:  Yao Liu; Hao Chen; Zheng Sun; Xiaoxin Chen
Journal:  Cancer Lett       Date:  2015-03-09       Impact factor: 8.679

8.  Association between gastric cardia adenocarcinoma risk and alcohol flushing response, but not alcohol consumption.

Authors:  Qingxu Song; Peng Hu; Jianbo Wang; Yibin Jia; Guangyu Zhang; Li Lv; Yuan Liu; Yufeng Cheng
Journal:  Med Oncol       Date:  2014-01-30       Impact factor: 3.064

9.  Primum Non Nocere: Should Gene Therapy Be Used to Prevent Potentially Fatal Disease but Enable Potentially Destructive Behavior?

Authors:  Inmaculada de Melo-Martin; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2021-04-26       Impact factor: 4.793

Review 10.  The alcohol flushing response: an unrecognized risk factor for esophageal cancer from alcohol consumption.

Authors:  Philip J Brooks; Mary-Anne Enoch; David Goldman; Ting-Kai Li; Akira Yokoyama
Journal:  PLoS Med       Date:  2009-03-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.